We examined circadian blood pressure (BP) variation (expressed as a relative night-time BP decline) in subjects with primary aldosteronism (78 patients), pheochromocytoma (n ¼ 45) and Cushing's syndrome (n ¼ 18). Subjects with aldosterone-producing adenoma (n ¼ 21) and pheochromocytoma (n ¼ 27) were also investigated after the tumour removal. In all, 65 patients with essential hypertension served as a control group. The night-time BP decline was significantly attenuated in all three forms of endocrine hypertension compared to the control group (primary aldosteronism Po0.0001, pheochromocytoma Po0.0001 for systolic and diastolic BP and Cushing's syndrome Po0.0001/o0.001 vs essential hypertension). In the case of pheochromocytoma, the absence of the night-time BP decrease was more prominent compared to the primary aldosteronism group (P ¼ 0.003/0.001) and for the diastolic BP also in comparison with the Cushing's syndrome group (P ¼ 0.03). Tumour removal led in both groups to the restoration of the previously altered circadian rhythm (aldosterone-producing adenoma: P ¼ 0.0005/0.0009; pheochromocytoma: P ¼ 0.001/0.0007). Our study demonstrates a blunted circadian BP variation in all forms of adrenal hypertension in comparison with essential hypertension. This reduction of the night-time BP decrease was more prominent in pheochromocytoma than in primary aldosteronism or Cushing's syndrome.
Introduction
Endocrine (adrenal) hypertension is often accompanied by altered diurnal blood pressure (BP) variation. [1] [2] [3] [4] [5] [6] However, these observations are of limited value because either a small number of studied subjects have been used in previous reports (especially in the case of pheochromocytoma) or controversial results have been published regarding the circadian BP pattern in primary aldosteronism and also in pheochromocytoma. 1, 2, [7] [8] [9] [10] [11] [12] [13] [14] Until now, no study has been focused on differences in diurnal BP variations between the steroid-and catecholamine-induced hypertension.
In our study, we investigated the diurnal BP pattern in groups of subjects with different forms of adrenal hypertension, either caused by the elevation of the steroid hormonesFprimary aldosteronism (aldosterone) and Cushing's syndrome (cortisol), which act mainly as Na + retaining factors (especially aldosterone)For by elevated catecholamines in pheochromocytoma, resulting in elevated sympathetic tone. Specific treatment effects of tumour removal on the diurnal BP variations were also studied to support the hypothesis of the preoperatively altered circadian BP pattern in endocrine hypertension.
Materials and methods
For the purpose of our study, 78 subjects with primary aldosteronism, 45 subjects with pheochromocytoma and 18 subjects with Cushing's syndrome were investigated between 1994 and 2002 (baseline characteristics are shown in Table 1 ). These patients were sent to our department because of suspicion of each endocrine disorder or to exclude the secondary form of hypertension in the case of refractory hypertension. All subjects were investigated in the course of hospitalisation either without antihypertensive treatment or, if necessary, they were switched on the treatment with a 1 -blockers at least 2 weeks before admission. Physiological activity was similar among all investigated subjects due to the hospitalisation.
Diagnosis of each endocrine disorder was confirmed by means of usual standard diagnostic tests. To diagnose primary aldosteronism, either stimulation (posture study) or suppression tests were performed to confirm the autonomous aldosterone production (elevated plasma aldosterone/plasma renin activity ratio 450 ng/100 ml/ng/ml/h with suppressed plasma renin activity values (o0.7 ng/ ml/h) and plasma aldosterone levels at least at the upper range of normal reference values (4150 ng/l)). CT scans and, if necessary, adrenal vein sampling were performed to lateralise the aldosterone production. In the case of aldosterone-producing adenoma, adrenalectomy was performed. Of these patients, 21 subjects were investigated 6-12 months after the operation.
Significantly elevated 24-h urinary catecholamines (analysis performed by means of fluorimetry or high-performance liquid chromatography)Fepinephrine or norepinephrinFwere considered as a diagnostic tool to diagnose pheochromocytoma. The tumour was then localised using CT or MRI and adrenalectomy (in the case of adrenal pheochromocytoma) or tumour removal (in the case of extra-adrenal pheochromocytoma) after medical pretreatment with a 1 -and betablockers was performed. In total, 27 subjects were investigated 6-12 months after a successful operation.
Nonsuppressible plasma cortisol levels after 1 mg midnight dexamathasone and elevated urinary free cortisol were necessary as the first step to diagnose Cushing's syndrome. For differential diagnosis of each form of Cushing's syndrome, plasma ACTH levels were established and, if necessary, other specific hormonal tests were performed to discriminate between the Cushing disease and ectopic ACTH production. Adrenal tumors were localised by CT, hypophysis was investigated by MRI and, if necessary, sampling of the sinus petrosus inferior was also performed. No subject with Cushing's syndrome was investigated after the successful tumour removal because of the long-term restitution of the hypothalamus-hypophysis-adrenal axis.
The diagnosis of essential hypertension was made after ruling out all possible causes of secondary hypertension under the same conditions as in subjects with endocrine hypertension.
All hormonal tests (except urinary free catecholamines) were performed using commercial RIA analysis.
Casual BP values were obtained in the sitting position by using a standard mercury sphygmomanometer according to ISH recommendations. Ambulatory BP monitoring was performed with an oscillometric device SpaceLabs 90207 (SpaceLabs Medical, Richmond, USA), which was set to measure blood pressure during the day (from 600 till 2200 h) every 20 min and during the night (from 2200 till 600 h) every 30 min. At the beginning and at the end of ambulatory BP monitoring, BP values obtained with ambulatory BP monitoring were checked against those BP values obtained with a standard mercury sphygmomanometer; a maximum difference of 7 5 mmHg was accepted as adequate agreement between the two methods. The vast majority of readings was performed by one investigator (TZ). Diurnal BP variation was characterised by the relative night BP decline calculated as follows: (day-time BPÀnight-time BP)/day-time BP Â 100%.
The data are shown as means 7 s.d. Analysis of variance was used to compare the variables among the studied groups and the control group. Changes in paired values (data before and after treatment) were analysed using the paired t-test. Po0.05 values were considered to be significant.
Results
Subjects with primary aldosteronism had the highest office and 24-h BP values in comparison with subjects with essential hypertension and also pheochromocytoma and Cushing's syndrome (Table 1) . Patients with essential hypertension had significantly higher office systolic and diastolic BP values Diurnal blood pressure in endocrine hypertension T Zelinka et al compared to the pheochromocytoma group and higher diastolic office BP in comparison with subjects with Cushing's syndrome (Table 1 ), but no difference was found in 24-h BP values among these three groups of patients (Table 2 ). Significant attenuation of the relative night-time systolic BP decline was found in all three groups with endocrine hypertension in comparison with essential hypertension (Figure 1, Po0.0001) . Subjects with pheochromocytoma had the highest degree of absence of nocturnal systolic BP decrease especially compared to subjects with primary aldosteronism (Figure 1, Po0.003) . Results for the night-time diastolic BP decrease were similar: significant reduction was observed in all three groups of subjects with endocrine hypertension in comparison with essential hypertension (Figure 2 , Po0.0001), and also the absence of the night-time diastolic BP fall was more expressed in the pheochromocytoma group than in subjects with primary aldosteronism and Cushing's syndrome (Figure 2 , Po0.001 vs primary aldosteronism and Po0.03 vs Cushing's syndrome). No differences in the relative night-time heart rate decrease were found among the groups with adrenal hypertension and essential hypertension (results not shown).
Tumour removal led in both groups of subjects with primary aldosteronism and pheochromocytoma to a significant reduction of 24-h BP values and to the significant elevation of the preoperatively attenuated relative night BP decrease (Tables 2 and  3) . No changes in the circadian heart rate variation before and after the treatment in both groups were noted (results not shown).
Discussion
In our study, we have demonstrated the attenuation of circadian BP variation in all forms of adrenal hypertension in comparison with essential hypertension. This phenomenon was expressed more in pheochromocytoma than in the steroid-induced adrenal hypertension (primary aldosteronism and Cushing's syndrome). Both steroid-induced types of hypertension had similar circadian BP characteristics. This finding is in concordance with the results of Middeke, but the number of subjects in each group with endocrine hypertension used in this study was very small. 1 The second study focused on assessing of circadian BP variation in endocrine disorders found diminished diurnal BP variation only in pheochromocytoma subjects but not in primary aldosteronism. 2 The difference in the circadian BP variation between pheochromocytoma and steroid-induced adrenal hypertension shows that different pathophysiological condition leads to the different attenuation of the circadian BP rhythmicity. In the case of pheochromocytoma, perhaps the most important factor contributing to the altered or inverted circadian BP variation is the tendency to the orthostatic hypotension with normally functioning baroreflex, which leads to BP falls and heart rate elevations during the active period of the day, and, on the contrary, to relatively inverted BP (reflecting thus higher sympathetic tone) and heart rate values during the night-time (in our study 18 subjects with pheochromocytoma had inverted circadian BP rhythm). 15, 16 Attenuation of night-time BP decline APAFaldosterone-producing adenoma, BPFblood pressure.
Diurnal blood pressure in endocrine hypertension T Zelinka et al was also found in normotensive subjects with pheochromocytoma, showing thus that the desensitisation of the cardiovascular system to catecholamines in pheochromocytoma (responsible for the wide variety of symptoms in pheochromoctoma) is not complete. 17, 18 In our study, subjects with pheochromocytoma had the lowest BP values compared not only to primary aldosteronism and Cushing's syndrome, but also to essential hypertension (eight subjects with pheochromocytoma were normotensive).
Concerning diurnal BP variation in primary aldosteronism, many studies were published with controversial results.
1,2,4-6,11-14 However, the last studies showed the influence of a high-salt diet on attenuation of night-time BP decrease as a sign of the night-time pressure natriuresis in subjects with aldosterone-producing adenoma. 5, 19 In the study of Wu et al, 19 the night-time BP decrease was diminished in subjects with abnormal response to metoclopramid on dopaminergic activityF'nonsuppresible' subjects had lower dopaminergic inhibition of aldosterone secretion, lower urinary dopamine excretion, higher BP increase and lower night-time BP decrease. Low sodium diet was then accompanied with the dipping type of the circadian BP profile. 5, 20 The characteristics of diurnal BP variation in subjects with Cushing's syndrome were similar to those with primary aldosteronism and also in concordance with the only study assessing the circadian BP rhythm in this pathophysiological condition. 3 We hypothesise that the Na + retaining action of cortisol may also in these subjects contribute to the alteration of the circadian BP rhythm, although the mechanisms as to how cortisol elevates BP are not completely understood. 21 Improvement of the previously altered circadian BP variation after successful tumour removal was shown in both types of adrenal hypertensionFin pheochromocytoma and in aldosterone-producing adenoma.
In summary, we showed a significant reduction of diurnal BP variation in each form of endocrine (adrenal) hypertension in comparison to essential hypertension. This reduction was more pronounced in pheochromocytoma than in primary aldosteronism or Cushing's syndrome. Specific treatment of each endocrine disorder (pheochromocytoma, primary aldosteronism) led to the normalisation of the previously altered diurnal BP variation. Subjects with pheochromocytoma had the lowest BP values among subjects with endocrine hypertension. Diurnal blood pressure in endocrine hypertension T Zelinka et al
